Trial Outcomes & Findings for Views on COVID-19 and Vaccination (NCT NCT04706403)

NCT ID: NCT04706403

Last Updated: 2022-05-24

Results Overview

All participants were asked about their intent to be vaccinated against COVID-19 prior to exposure to one of the five physician messages (Response options: Yes, No, Not sure). After participants were randomly assigned to receive one of the five physician messages, reduction in COVID-19 vaccine hesitancy was assessed with the question: "Would you get vaccinated at this visit". Response options included yes, no, not sure. For participants whose initial vaccination intent was "not sure", a response of "yes" on re-assessment was defined as less hesitant. Response of "not sure" or "yes" were defined as less hesitant for participants whose initial vaccination intent was "no".

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

756 participants

Primary outcome timeframe

Through survey completion, an average of 12 minutes

Results posted on

2022-05-24

Participant Flow

Participants were recruited on Prolific.co from 01/12/21-02/01/21. Eligible panel members were \>= 18, English speaking, and U.S residents. Panel members were restricted to include White, Black, or Hispanic; Blacks and Hispanics were oversampled. Participants who responded "no" or "not sure" to "If you could get vaccinated for COVID-19 today, would you?" were classified as vaccine hesitant and randomized to receive 1 of 5 physician messages, after which their intent was reassessed.

Participant milestones

Participant milestones
Measure
Message 1
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
Message 2
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
Message 3
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
Message 4
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
Message 5
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
Overall Study
STARTED
172
121
165
146
152
Overall Study
COMPLETED
172
121
164
145
150
Overall Study
NOT COMPLETED
0
0
1
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Message 1
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
Message 2
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
Message 3
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
Message 4
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
Message 5
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
Overall Study
Participants did not provide respond to the question re-assessing vaccination intent
0
0
1
1
2

Baseline Characteristics

Views on COVID-19 and Vaccination

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Message 1
n=172 Participants
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
Message 2
n=121 Participants
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
Message 3
n=164 Participants
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
Message 4
n=145 Participants
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgement of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
Message 5
n=150 Participants
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
Total
n=752 Participants
Total of all reporting groups
Age, Customized
Age · Less than 24 years
43 Participants
n=5 Participants
31 Participants
n=7 Participants
37 Participants
n=5 Participants
38 Participants
n=4 Participants
41 Participants
n=21 Participants
190 Participants
n=10 Participants
Age, Customized
Age · 25 - 34 years
40 Participants
n=5 Participants
32 Participants
n=7 Participants
42 Participants
n=5 Participants
28 Participants
n=4 Participants
42 Participants
n=21 Participants
184 Participants
n=10 Participants
Age, Customized
Age · 35 - 44 years
50 Participants
n=5 Participants
27 Participants
n=7 Participants
31 Participants
n=5 Participants
50 Participants
n=4 Participants
33 Participants
n=21 Participants
191 Participants
n=10 Participants
Age, Customized
Age · 45 - 54 years
22 Participants
n=5 Participants
21 Participants
n=7 Participants
27 Participants
n=5 Participants
17 Participants
n=4 Participants
20 Participants
n=21 Participants
107 Participants
n=10 Participants
Age, Customized
Age · 55 - 64 years
13 Participants
n=5 Participants
4 Participants
n=7 Participants
20 Participants
n=5 Participants
10 Participants
n=4 Participants
11 Participants
n=21 Participants
58 Participants
n=10 Participants
Age, Customized
Age · 65 years or older
3 Participants
n=5 Participants
5 Participants
n=7 Participants
3 Participants
n=5 Participants
2 Participants
n=4 Participants
2 Participants
n=21 Participants
15 Participants
n=10 Participants
Age, Customized
Age · Missing
1 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
7 Participants
n=10 Participants
Sex/Gender, Customized
Gender · Male
62 Participants
n=5 Participants
41 Participants
n=7 Participants
71 Participants
n=5 Participants
52 Participants
n=4 Participants
65 Participants
n=21 Participants
291 Participants
n=10 Participants
Sex/Gender, Customized
Gender · Female
108 Participants
n=5 Participants
78 Participants
n=7 Participants
88 Participants
n=5 Participants
93 Participants
n=4 Participants
82 Participants
n=21 Participants
449 Participants
n=10 Participants
Sex/Gender, Customized
Gender · Other
0 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
6 Participants
n=10 Participants
Sex/Gender, Customized
Gender · Prefer not to say
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
1 Participants
n=10 Participants
Sex/Gender, Customized
Gender · Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
3 Participants
n=21 Participants
5 Participants
n=10 Participants
Race/Ethnicity, Customized
Hispanic/Latino
35 Participants
n=5 Participants
31 Participants
n=7 Participants
41 Participants
n=5 Participants
33 Participants
n=4 Participants
37 Participants
n=21 Participants
177 Participants
n=10 Participants
Race/Ethnicity, Customized
Black/African American
79 Participants
n=5 Participants
52 Participants
n=7 Participants
66 Participants
n=5 Participants
64 Participants
n=4 Participants
65 Participants
n=21 Participants
326 Participants
n=10 Participants
Race/Ethnicity, Customized
White
58 Participants
n=5 Participants
37 Participants
n=7 Participants
57 Participants
n=5 Participants
48 Participants
n=4 Participants
48 Participants
n=21 Participants
248 Participants
n=10 Participants
Race/Ethnicity, Customized
Missing
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
1 Participants
n=10 Participants
Region of Enrollment
United States
172 participants
n=5 Participants
121 participants
n=7 Participants
164 participants
n=5 Participants
145 participants
n=4 Participants
150 participants
n=21 Participants
752 participants
n=10 Participants
Initial Vaccination Intent
Initially "No"
103 Participants
n=5 Participants
66 Participants
n=7 Participants
83 Participants
n=5 Participants
78 Participants
n=4 Participants
81 Participants
n=21 Participants
411 Participants
n=10 Participants
Initial Vaccination Intent
Initially "Not Sure"
69 Participants
n=5 Participants
55 Participants
n=7 Participants
81 Participants
n=5 Participants
67 Participants
n=4 Participants
69 Participants
n=21 Participants
341 Participants
n=10 Participants
Education
High School or Less
44 Participants
n=5 Participants
40 Participants
n=7 Participants
53 Participants
n=5 Participants
38 Participants
n=4 Participants
49 Participants
n=21 Participants
224 Participants
n=10 Participants
Education
Some college
86 Participants
n=5 Participants
56 Participants
n=7 Participants
85 Participants
n=5 Participants
70 Participants
n=4 Participants
68 Participants
n=21 Participants
365 Participants
n=10 Participants
Education
4-year college or more
42 Participants
n=5 Participants
25 Participants
n=7 Participants
25 Participants
n=5 Participants
36 Participants
n=4 Participants
32 Participants
n=21 Participants
160 Participants
n=10 Participants
Education
Missing
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
1 Participants
n=21 Participants
3 Participants
n=10 Participants
Employment
Employed
88 Participants
n=5 Participants
64 Participants
n=7 Participants
83 Participants
n=5 Participants
83 Participants
n=4 Participants
76 Participants
n=21 Participants
394 Participants
n=10 Participants
Employment
Unemployed
30 Participants
n=5 Participants
20 Participants
n=7 Participants
29 Participants
n=5 Participants
20 Participants
n=4 Participants
30 Participants
n=21 Participants
129 Participants
n=10 Participants
Employment
Student
25 Participants
n=5 Participants
15 Participants
n=7 Participants
15 Participants
n=5 Participants
19 Participants
n=4 Participants
18 Participants
n=21 Participants
92 Participants
n=10 Participants
Employment
Homemaker
16 Participants
n=5 Participants
12 Participants
n=7 Participants
9 Participants
n=5 Participants
14 Participants
n=4 Participants
13 Participants
n=21 Participants
64 Participants
n=10 Participants
Employment
Disabled
6 Participants
n=5 Participants
3 Participants
n=7 Participants
10 Participants
n=5 Participants
4 Participants
n=4 Participants
5 Participants
n=21 Participants
28 Participants
n=10 Participants
Employment
Retired
3 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
4 Participants
n=4 Participants
4 Participants
n=21 Participants
21 Participants
n=10 Participants
Employment
Other
4 Participants
n=5 Participants
3 Participants
n=7 Participants
10 Participants
n=5 Participants
1 Participants
n=4 Participants
4 Participants
n=21 Participants
22 Participants
n=10 Participants
Employment
Missing
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
2 Participants
n=10 Participants
Household Income
Less than $30,000
47 Participants
n=5 Participants
43 Participants
n=7 Participants
55 Participants
n=5 Participants
40 Participants
n=4 Participants
57 Participants
n=21 Participants
242 Participants
n=10 Participants
Household Income
$30,000 - $60,000
53 Participants
n=5 Participants
41 Participants
n=7 Participants
57 Participants
n=5 Participants
51 Participants
n=4 Participants
53 Participants
n=21 Participants
255 Participants
n=10 Participants
Household Income
$60,000 - $100,000
44 Participants
n=5 Participants
27 Participants
n=7 Participants
35 Participants
n=5 Participants
26 Participants
n=4 Participants
27 Participants
n=21 Participants
159 Participants
n=10 Participants
Household Income
More than $100,000
21 Participants
n=5 Participants
7 Participants
n=7 Participants
11 Participants
n=5 Participants
19 Participants
n=4 Participants
9 Participants
n=21 Participants
67 Participants
n=10 Participants
Household Income
Prefer not to answer
6 Participants
n=5 Participants
2 Participants
n=7 Participants
5 Participants
n=5 Participants
9 Participants
n=4 Participants
3 Participants
n=21 Participants
25 Participants
n=10 Participants
Household Income
Missing
1 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
4 Participants
n=10 Participants
Geographic region
South
90 Participants
n=5 Participants
66 Participants
n=7 Participants
80 Participants
n=5 Participants
75 Participants
n=4 Participants
80 Participants
n=21 Participants
391 Participants
n=10 Participants
Geographic region
Midwest
28 Participants
n=5 Participants
17 Participants
n=7 Participants
34 Participants
n=5 Participants
31 Participants
n=4 Participants
21 Participants
n=21 Participants
131 Participants
n=10 Participants
Geographic region
West
28 Participants
n=5 Participants
21 Participants
n=7 Participants
23 Participants
n=5 Participants
15 Participants
n=4 Participants
33 Participants
n=21 Participants
120 Participants
n=10 Participants
Geographic region
Northeast
26 Participants
n=5 Participants
17 Participants
n=7 Participants
27 Participants
n=5 Participants
24 Participants
n=4 Participants
16 Participants
n=21 Participants
110 Participants
n=10 Participants
History of flu shot
Ever, in the last 5 years
73 Participants
n=5 Participants
40 Participants
n=7 Participants
70 Participants
n=5 Participants
78 Participants
n=4 Participants
71 Participants
n=21 Participants
332 Participants
n=10 Participants
History of flu shot
Not sure or no
99 Participants
n=5 Participants
81 Participants
n=7 Participants
93 Participants
n=5 Participants
67 Participants
n=4 Participants
79 Participants
n=21 Participants
419 Participants
n=10 Participants
History of flu shot
Missing
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
1 Participants
n=10 Participants
Self-rated overall health
Excellent
22 Participants
n=5 Participants
12 Participants
n=7 Participants
13 Participants
n=5 Participants
9 Participants
n=4 Participants
13 Participants
n=21 Participants
69 Participants
n=10 Participants
Self-rated overall health
Very good
44 Participants
n=5 Participants
34 Participants
n=7 Participants
48 Participants
n=5 Participants
40 Participants
n=4 Participants
39 Participants
n=21 Participants
205 Participants
n=10 Participants
Self-rated overall health
Good
69 Participants
n=5 Participants
51 Participants
n=7 Participants
66 Participants
n=5 Participants
58 Participants
n=4 Participants
65 Participants
n=21 Participants
309 Participants
n=10 Participants
Self-rated overall health
Fair
27 Participants
n=5 Participants
19 Participants
n=7 Participants
34 Participants
n=5 Participants
33 Participants
n=4 Participants
24 Participants
n=21 Participants
137 Participants
n=10 Participants
Self-rated overall health
Poor
9 Participants
n=5 Participants
5 Participants
n=7 Participants
3 Participants
n=5 Participants
5 Participants
n=4 Participants
8 Participants
n=21 Participants
30 Participants
n=10 Participants
Self-rated overall health
Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
2 Participants
n=10 Participants
Self-rated overall mental health
Excellent
22 Participants
n=5 Participants
17 Participants
n=7 Participants
22 Participants
n=5 Participants
12 Participants
n=4 Participants
18 Participants
n=21 Participants
91 Participants
n=10 Participants
Self-rated overall mental health
Very good
43 Participants
n=5 Participants
31 Participants
n=7 Participants
37 Participants
n=5 Participants
33 Participants
n=4 Participants
30 Participants
n=21 Participants
174 Participants
n=10 Participants
Self-rated overall mental health
Good
42 Participants
n=5 Participants
38 Participants
n=7 Participants
48 Participants
n=5 Participants
47 Participants
n=4 Participants
50 Participants
n=21 Participants
225 Participants
n=10 Participants
Self-rated overall mental health
Fair
51 Participants
n=5 Participants
20 Participants
n=7 Participants
39 Participants
n=5 Participants
35 Participants
n=4 Participants
40 Participants
n=21 Participants
185 Participants
n=10 Participants
Self-rated overall mental health
Poor
14 Participants
n=5 Participants
15 Participants
n=7 Participants
18 Participants
n=5 Participants
17 Participants
n=4 Participants
12 Participants
n=21 Participants
76 Participants
n=10 Participants
Self-rated overall mental health
Missing
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
0 Participants
n=21 Participants
1 Participants
n=10 Participants

PRIMARY outcome

Timeframe: Through survey completion, an average of 12 minutes

Population: Four participants were excluded from the analyses because they did not respond to the question re-assessing vaccination intent following exposure to a physician recommendation.

All participants were asked about their intent to be vaccinated against COVID-19 prior to exposure to one of the five physician messages (Response options: Yes, No, Not sure). After participants were randomly assigned to receive one of the five physician messages, reduction in COVID-19 vaccine hesitancy was assessed with the question: "Would you get vaccinated at this visit". Response options included yes, no, not sure. For participants whose initial vaccination intent was "not sure", a response of "yes" on re-assessment was defined as less hesitant. Response of "not sure" or "yes" were defined as less hesitant for participants whose initial vaccination intent was "no".

Outcome measures

Outcome measures
Measure
Message 1
n=172 Participants
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
Message 2
n=121 Participants
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
Message 3
n=164 Participants
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
Message 4
n=145 Participants
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
Message 5
n=150 Participants
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
Number of Participants Who Became Less Hesitant About the COVID-19 Vaccine After Receiving a Physician Message
23 Participants
26 Participants
43 Participants
35 Participants
40 Participants

Adverse Events

Message 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Message 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Message 3

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Message 4

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Message 5

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Kimberly Fisher

UMass Chan Medical School

Phone: (508)8561975

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place